Expression of the angiogenic mediator, angiopoietin-like 4, in the eyes of patients with proliferative sickle retinopathy

The recent success of therapies directly targeting the angiogenic mediator, vascular endothelial growth factor (VEGF), for the treatment of proliferative diabetic retinopathy has encouraged clinicians to extend the use of anti-VEGF therapies for the treatment of another ischemic retinal vascular dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Jee, Kathleen, Rodrigues, Murilo, Kashiwabuchi, Fabiana, Applewhite, Brooks P., Han, Ian, Lutty, Gerard, Goldberg, Morton F., Semenza, Gregg L., Montaner, Silvia, Sodhi, Akrit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568377/
https://www.ncbi.nlm.nih.gov/pubmed/28832635
http://dx.doi.org/10.1371/journal.pone.0183320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568377/
https://www.ncbi.nlm.nih.gov/pubmed/28832635
http://dx.doi.org/10.1371/journal.pone.0183320

Ejemplares similares